CPOAX
Price
$40.10
Change
+$0.69 (+1.75%)
Updated
Dec 20 closing price
RGAHX
Price
$74.23
Change
+$0.67 (+0.91%)
Updated
Dec 20 closing price
Ad is loading...

CPOAX vs RGAHX

Header iconCPOAX vs RGAHX Comparison
Open Charts CPOAX vs RGAHXBanner chart's image
Morgan Stanley Insight A
Price$40.10
Change+$0.69 (+1.75%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$74.23
Change+$0.67 (+0.91%)
VolumeN/A
CapitalizationN/A
CPOAX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CPOAX vs. RGAHX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPOAX is a Hold and RGAHX is a Buy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 301B vs. CPOAX (1.51B). RGAHX pays higher dividends than CPOAX: RGAHX (0.64) vs CPOAX (0.00). CPOAX was incepted earlier than RGAHX: CPOAX (27 years) vs RGAHX (9 years). CPOAX is a more actively managed with annual turnover of: 40.00 vs. RGAHX (31.00). RGAHX has a lower initial minimum investment than CPOAX: RGAHX (250) vs CPOAX (1000). CPOAX annual gain was more profitable for investors over the last year : 51.80 vs. RGAHX (20.09). RGAHX return over 5 years is better than : 48.93 vs. CPOAX (-0.61).
CPOAXRGAHXCPOAX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years9 years-
Gain YTD52.83319.648269%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.51B301B1%
Annual Yield % from dividends0.000.64-
Returns for 1 year51.8020.09258%
Returns for 3 years-40.034.57-876%
Returns for 5 years-0.6148.93-1%
Returns for 10 years24.67N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLTR80.556.34
+8.54%
Palantir Technologies
LUCD0.780.01
+1.31%
Lucid Diagnostics
HMY8.430.09
+1.08%
Harmony Gold Mining Company Limited
RVNC3.090.02
+0.65%
Revance Therapeutics
PCRX18.98-0.59
-3.01%
Pacira BioSciences